Therefore, it is conceivable that the reduction of p-PKM2 Tyr105 levels in response to EGFR inhibitors promotes tetramer formation and a high enzymatic catalytic activity in NSCLC that in turn may redirect pyruvate flux toward mitochondrial oxidative phosphorylation [27]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.